Jefferies Financial Group downgraded shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) from a buy rating to a hold rating in a research report report published on Friday morning, FlyOnTheWall reports. A number of other equities analysts have also weighed in on HZNP. TheStreet lowered shares of Horizon Therapeutics Public from a b- rating […]
Oxford Financial Group Ltd. bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,500 shares of the biopharmaceutical company’s stock, valued at approximately $273,000. Other hedge funds […]
Jefferies Financial Group cut shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning, FlyOnTheWall reports. Several other equities research analysts have also recently issued reports on the stock. TheStreet cut shares of Horizon Therapeutics Public from a […]
Oxford Financial Group Ltd. bought a new position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 2,500 shares of the biopharmaceutical company’s stock, valued at approximately $273,000. Other institutional investors and hedge […]
BCK Capital Management LP trimmed its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 63.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 74,278 shares of the biopharmaceutical company’s stock after selling 128,329 shares during the quarter. Horizon Therapeutics Public comprises […]